Health Policy
-
Here’s why CMS’s move to reimburse for virtual care and remote patient monitoring is good but not great
The new rule includes additional amendments designed to accelerate the use of virtual check-ins and Remote Patient Monitoring in the market. Here’s a look at why the rule is good but not great.
-
Trump administration wants to overhaul Medicare accountable care organization program
Seema Verma, administrator of the Centers for Medicare & Medicaid Services, said it’s wrong to have ACOs that can only make profits but not risk any losses. “We want to put the accountability back into Accountable Care Organizations,” she said during a briefing with reporters.
-
In-home care positioned to play a key role in the consumerization of healthcare
Eddie Peloke, CEO of Workpath, spoke to why in-home care can drive the next stage of this industry-wide movement
-
Trump administration slashes funding to insurance navigator groups months ahead of open enrollment for ACA
CMS Administrator Seema Verma said the navigators that operate in the 34 states that use the federal marketplace — including many health and religious organizations — were ineffective and had outlived their usefulness.
-
Senate Democrats make protecting ACA rallying cry for opposition to Supreme Court nominee
“The Supreme Court will ultimately decide if nearly 800,000 West Virginians with pre-existing conditions will lose their healthcare,” said U.S. Senator Joe Manchin (D-West Virginia)
-
California Attorney General: Trump admin has gone ‘AWOL’ on ACA insured patients
California Attorney General Xavier Becerra said attacks by the Trump Administration threaten healthcare for millions of Americans.
-
CMS administrator declines to share her own conclusions on Medicaid ‘scorecard’
Seema Verma, administrator of the Centers for Medicare and Medicaid Services, refused to discuss the findings in any detail or comment on any individual states that performed poorly or exceptionally.
-
Trump’s drug cost cutting plans include transparency, but critics doubt much will change
In his plans to cut sky-high drug prices unveiled Friday, Trump said that increasing industry competition will help Americans save at the pharmacy counter.
-
This is why Novartis paid Trump’s lawyer Michael Cohen $1.2 million
Hiring the president’s personal attorney matches a history of aggressively courting government officials by a corporation with much to lose in the debate over high drug prices.
-
What will be impact of Trump’s plan to rescind Children’s Health Insurance Program funding?
CHIP, which covers 9 million children from low-income families that earn too much to qualify for Medicaid, is mostly federally funded. But states operate the program within federal guidelines.
-
Improving health in one of the most complex and costly chronic conditions
Kidney care in the U.S. needs an overhaul. Changing today’s expensive, disconnected care model requires moving from volume to value.
Misha Palecek, Chief Transformation Officer, DaVita Kidney Care
-
A look at how one pharma company responded to the pressure on drug prices: Ramping up political activity
The pharma industry as a whole has cranked up political contributions and lobbying. Meanwhile, despite much talk about change, Congress and the Trump administration have done little to control drug prices or threaten drug-company profits.
-
Federal appeals court pours cold water on Maryland’s efforts to reign in prescription drug prices
A 2-to-1 ruling by the U.S. 4th Circuit Court of Appeals invalidated a Maryland law meant to limit “price-gouging” by makers of generic drugs. The appeals court held that Maryland’s law overstepped limits on how states can regulate commerce.
-
Just make Steve Cohen V.A. Secretary and get it over with
President Donald Trump should name hedge fund manager Steve Cohen as Secretary for Veterans Affairs instead of Trump’s personal physician Ronny Jackson.
-
This ACA timeline illustrates how the health law has been changed since Trump took office
Here is a timeline of the most consequential events that have shaped the health law through the Trump Administration’s and GOP’s “repeal and replace” efforts in Congress.
-
Right to Try legislation to ease rules on experimental drug access falters in House vote
Although the Senate handily passed a proposal authorizing Right to Try in August, the House vote failed to get a two-thirds majority with a vote of 259 to 140.
-
Human API and CMS collaborate to help Medicare patients share claims data in new chapter for Blue Button
CMS has recruited more than 100 organizations to join the CMS Medicare Blue Button 2.0 developer preview program, which was announced at the HIMSS conference in Las Vegas this week.



